Artal Group S.A. Kronos Bio, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.75 - $1.49 $525,000 - $1.04 Million	-700,000 Reduced 45.37%	842,954 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$11.35 - $21.18 $2.55 Million - $4.77 Million	225,000 Added 17.07%	1,542,954 $21 Million
Q4 2020 Feb 11, 2021	BUY	$26.68 - $38.23 $35.2 Million - $50.4 Million	1,317,954 New	1,317,954 $39.4 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.